Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | +0.63% | -2.75% | -40.56% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
Financials (USD)
Sales 2024 * | 112M | Sales 2025 * | 124M | Capitalization | 137M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 3M | EV / Sales 2024 * | 1.23 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
-39.8
x | P/E ratio 2025 * |
42.4
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | +0.63% | ||
1 week | -2.75% | ||
Current month | -16.75% | ||
1 month | -12.15% | ||
3 months | -28.05% | ||
6 months | -28.38% | ||
Current year | -40.56% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 3.18 | +0.63% | 159,639 |
24-05-24 | 3.16 | -0.63% | 336,626 |
24-05-23 | 3.18 | -3.64% | 119,811 |
24-05-22 | 3.3 | +0.92% | 87,398 |
24-05-21 | 3.27 | 0.00% | 42,585 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.56% | 137M | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- HBIO Stock